Rhythmia
Device Diagnostic
General payments
$572,299
Research payments
$753,174
Through program year 2021, $572,299 in general payments and $753,174 in research payments were reported against Rhythmia (Diagnostic).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $31 | 1 |
| 2020 | General | $129,745 | 817 |
| 2020 | Research | $269,045 | 7 |
| 2019 | General | $442,524 | 1,931 |
| 2019 | Research | $484,129 | 15 |
Breakdown
Each share is of general payments naming this product in 2021.
Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2021 where a state was reported.
Records
2,749 general · 22 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.